What Researchers Did
This study reviewed current treatment options for chronic radiation proctitis, highlighting the lack of robust evidence for most therapies.
What They Found
Chronic radiation proctitis affects 5-20% of patients after pelvic radiotherapy, with rectal bleeding being the most common symptom. The review found that while various treatments exist, including oral, rectal instillation, thermal, and hyperbaric oxygen therapies, robust evidence is lacking for most. Pragmatic approaches include sucralfate enemas and oral metronidazole, with thermal methods like heater probe or argon plasma coagulation appearing effective and safe.
What This Means for Canadian Patients
Patients experiencing chronic radiation proctitis symptoms after pelvic radiotherapy have several treatment options available, though the evidence supporting them varies. They should discuss these options, such as sucralfate enemas, oral metronidazole, or thermal therapies, with their healthcare providers to find a suitable management plan.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
The primary limitation is the lack of adequately powered, controlled, and blinded studies with standardised evaluation tools and sufficient follow-up for chronic radiation proctitis treatments.